World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT03155763
Date of registration: 13/05/2017
Prospective Registration: No
Primary sponsor: Andriy Trailin
Public title: Histology of Implantation Biopsies and Kidney Allograft Outcomes KALIMBO
Scientific title: Impact of Acute and Chronic Individual Histological Lesions and Composite Scores in Implantation Biopsies on Short-term and Long-term Kidney Allograft Outcomes
Date of first enrolment: April 1, 2005
Target sample size: 130
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03155763
Study type:  Observational
Study design:   
Phase:  N/A
Countries of recruitment
Ukraine
Contacts
Name:     Andriy V Trailin, MD, DSc
Address: 
Telephone:
Email:
Affiliation:  State Institution, Zaporizhzhia Medical Academy of Post-Graduate Education Ministry of Health of Ukraine
Key inclusion & exclusion criteria

Inclusion Criteria:

- adult kidney transplant recipients who underwent transplantation at Zaporizhzhia
Transplant Center;

- cadaveric or living single kidney only transplant;

- informed written consent;

- adequate intraoperative biopsy (in total = 7 glomeruli and = 1 arteries in preimplant
and postreperfusion biopsies);

- complete follow-up data up to 5 years.

Exclusion Criteria:

- not consent with research;

- non-complete follow-up data up to 5 years.



Age minimum: 18 Years
Age maximum: 70 Years
Gender: All
Health Condition(s) or Problem(s) studied
Kidney Graft Dysfunction
Intervention(s)
Procedure: Intraoperative kidney allograft preimplantation biopsy; Intraoperative kidney allograft postreperfusion biopsy
Primary Outcome(s)
Five-year death-censored kidney allograft survival [Time Frame: Five years]
Secondary Outcome(s)
Slow graft function [Time Frame: The day 8]
Pyelonephritis [Time Frame: During five years]
Acute rejection [Time Frame: During five years]
Delayed graft function [Time Frame: The day 8]
Allograft function at 1, 3, 6, 12 months, 2, 3, 4 and 5 years [Time Frame: During five years]
One-year death-censored kidney allograft survival [Time Frame: One year]
Secondary ID(s)
0105U007599
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history